Stocks-EXEL-Exelixis Inc

EXEL Exelixis Inc

18.57 0.24 (1.31%)
Delayed Prices By NASDAQ, in USD Market Closed
Invest
Stocks-EXEL-Exelixis Inc
EXEL Exelixis Inc
Invest

Performance

8.72% Past Week
Created with Highcharts 4.2.7 /Highstock 4.2.7
Market Cap
6.02B
Dayโ€™s Range
18.26
-
18.76
52W Range
14.85
-
23.37
Volume (3M)
3.07M
Price-Earnings Ratio
33.07
Revenue
1.61B

Exelixis Inc Latest News

View All
Exelixis Targeted As Activist Farallon Capital Partners Reveals 7.2% HoldingExelixis Targeted As Activist Farallon Capital Partners Reveals 7.2% HoldingValueWalkabout 2 hours agoExelixis Stock Shows Market Leadership, Earns 81 RS RatingExelixis Stock Shows Market Leadership, Earns 81 RS RatingInvestor's Business Dailyabout 9 hours agoWhy Exelixis Stock Leaped More Than 4% Higher TodayWhy Exelixis Stock Leaped More Than 4% Higher TodayThe Motley Foola day ago
Top Discussions
MarketUpdates
United Kingdom
about a month ago
Edited
$EXEL (Exelixis Inc) Q1 2023 earnings report is expected to be released
9
MAY
REPORTS
Exelixis Inc Q1 2023 earnings report is expected to be released after market open
Notify me
EXEL
EXEL
Exelixis Inc
18.57
0.24
(1.31%)
Trade
Like CommentShare
MarketUpdates
United Kingdom
about a month ago
Edited
$EXEL (Exelixis Inc) Q1 2023 earnings report is expected to be released
Like CommentShare
MarketUpdates
United Kingdom
about a month ago
$EXEL (Exelixis Inc) Q1 2023 earnings report is expected to be released
Like CommentShare
Henrik Bilevits
Sweden
2 months ago
๐—ฃ๐—˜๐—ฅ๐—™๐—ข๐—ฅ๐— ๐—”๐—ก๐—–๐—˜ ๐—๐—”๐—ก๐—จ๐—”๐—ฅ๐—ฌ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฏ The month of January was a relief compared to 2022, let's hope it continues in February. ๐— ๐˜† ๐—ฟ๐—ฒ๐˜€๐˜‚๐—น๐˜๐˜€ January: +9.24% ๐— ๐˜† ๐—ฟ๐—ฒ๐˜€๐˜‚๐—น๐˜๐˜€ ๐—ฐ๐—ผ๐—บ๐—ฝ๐—ฎ๐—ฟ๐—ฒ๐—ฑ ๐˜๐—ผ: โœ… SPX500 January: +6.18% โŒ NSDQ100 January: +10,62% โœ… Warren Buffet January:... Show More
Like CommentShare
null
.
Benjamin Nowak
Germany
2 months ago
๐˜ฟ๐™š๐™ฅ๐™ค๐™ฉ๐™ช๐™ฅ๐™™๐™–๐™ฉ๐™š โ€“ 18.01.2023 Ich habe ein paar Korrekturen an meinem Depot vorgenommen. Die Anpassungen sahen wie folgt aus: แด แด‡ส€แด‹แด€แดœา“ โ—ผ๏ธ $BLDR (Builders FirstSource Inc): Ich habe meine komplette Position mit einem Plus von knapp 17,5% zu einem Kurs von $72,60 geschlossen. Dadurch, dass sich... Show More Translate
Like CommentShare
null
.

About Exelixis Inc

Exelixis Inc is an American biotechnology company based in Alameda, California. Operating internationally, the firm is predominantly an oncology-focused, genomics-based research and drug discovery company involved in the discovery, development, and commercialisation of new therapies aimed at patients suffering from cancers that are traditionally difficult to treat. The firm was founded in 1994. The company is the producer of Cometriq, a treatment approved by the US Food and Drug Administration for the treatment of progressive, metastatic medullary thyroid cancer, and Cabometyx, a treatment for patients with advanced renal cell carcinoma. Other commercial products include Cotellic, a kinase inhibitor used in the treatment of patients with unresectable or metastatic melanoma. The firm has several other products in the pipeline at various stages, with a strong focus on small molecule drug discovery and biotherapeutic treatments primarily aimed at cancer patients. Exelixis Inc has acquired various related companies, including Genomica, Agritope, and X-Ceptor. The firm also collaborates with a number of partners in the industry, such as Invenra, who Exelixis Inc is working with on the development of cancer antibodies, antibody-drug conjugates, and other biologic candidates. The firm trades on the NASDAQ, where it is listed under the stock ticker EXEL. Track price movements by adding EXEL stock to your eToro watchlist.
1.2K
Employees
Alameda, California, US
HQ
1994
Founded
Michael M. Morrissey, PhD
CEO
Show More
Media ServicesNASDAQ

Upcoming Earnings

9
MAY
REPORTS
Exelixis Inc Q1 2023 earnings report is expected to be released after market open

Analyst Forecast

Consensus
Moderate Buy
Price Target
24.17
Based on 6 analysts who covered EXEL 

ESG: A New Source of Insight

What is an ESG Score?
This number is a measure of a companyโ€™s exposure to environmental, social, and governance risks. Influencing factors include energy efficiency, safety, social policies, and more. Learn More
Powered by ESG Book
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
59
High
Industry 
Avg. 49 
44
Environment
52
Social
67
Governance

People Also Bought